Quantcast
Home / Practice Areas / Personal Injury and Tort / J&J pushed Risperdal after warning, files show

J&J pushed Risperdal after warning, files show

The U.S. Attorney's office in Boston announced that the Justice Department has filed a False Claims Act complaint against Johnson & Johnson and two subsidiaries for allegedly paying millions of dollars in kickbacks to nursing homes to prescribe its anti-psychotic drug Risperdal.